Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Comparison of Beta-2 Microglobulin Level and Some Variables Between Thalassemia Major Patients Who Treated by Desferal and Control Group

Mandana Zafari 1 , * and Azar Aghamohammady 1
Authors Information
1 Health Reproductive Research Center, Sari Branch, Islamic Azad University, Sari, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: October 2017, 19 (10); e11538
  • Published Online: October 28, 2017
  • Article Type: Research Article
  • Received: May 25, 2017
  • Revised: July 9, 2017
  • Accepted: October 23, 2017
  • DOI: 10.5812/zjrms.11538

To Cite: Zafari M, Aghamohammady A. Comparison of Beta-2 Microglobulin Level and Some Variables Between Thalassemia Major Patients Who Treated by Desferal and Control Group, Zahedan J Res Med Sci. 2017 ; 19(10):e11538. doi: 10.5812/zjrms.11538.

Abstract
Copyright © 2017, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Zaid MY, Alhially YAH, Yahya Dallal Bashi A. Evaluation of conventional renal function tests in β- Thalassemia major patients in Nineveh province. Tikrit J Pharm Sci. 2012; 8(8): 6-14
  • 2. Hashemi A, Noorani F, Ayatollahi J, Jenabzadeh A, KHeirandish M. β-Thalassemia [In Persian]. J Shahid Sadooghi Univ Med Sci. 2008; 17(2): 87-95
  • 3. Mirbehbahani N, Jabari A, Mirkatooli N, Behnampor N. Serum feritin in Thalassemia (major) patients with subcutaneous desferal versus subcutaneous and intravenous desferal therapy. Iran J Pediatr. 2007; 17(2): 249-54
  • 4. Mohkam M, Nariman SH, SHamsian SH, Arzanian T, Gachkar L. NAG urine and related factor in Thalassemia major patients in Mofid hospital [In Persian]. Pjoohandeh. 2004; 10(3): 177-81
  • 5. Cappellini MD, Bejaoui M, Agaoglu L, Canatan D, Capra M, Cohen A, et al. Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood. 2011; 118(4): 884-93[DOI][PubMed]
  • 6. Economou M, Printza N, Teli A, Tzimouli V, Tsatra I, Papachristou F, et al. Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox. Acta Haematol. 2010; 123(3): 148-52[DOI][PubMed]
  • 7. Mansi K, Aburjai T, AlBashtawy M, Abdel-Dayem M. Biochemical factors relevant to kidney functions among Jordanian children with beta-thalassemia major treated with deferoxamine. Int J Med Med Sci. 2013; 5(8): 374-9[DOI]
  • 8. Doddamani P, Suma MN, Ravi MD, Prashant A, Vishwanath P, Nagalakshmi CS. Importance of assessment of microalbuminuria in β-thalassemia major patients. Int J Health Allied Sci. 2012; 1(4): 235[DOI]
  • 9. Hashemieh M, Azarkeivan A, Akhlaghpoor S, Shirkavand A, Sheibani K. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients. Arch Iran Med. 2012; 15(2): 91-4[PubMed]
  • 10. Soleimani AR, Morvveji SR, Arbabi M, Tamadon MR, Asadi M. Evaluation of plasma beta-2 microglobulin level in hemodialysis patients with carpal tunnel syndrome [In Persian]. Feyz J Kashan Univ Med Sci. 2012; 16(3): 324-9
  • 11. Ahmadzadeh A, Jalali A, Assar S, Khalilian H, Zandian K, Pedram M. Renal tubular dysfunction in pediatric patients with beta-thalassemia major. Saudi J Kidney Dis Transpl. 2011; 22(3): 497-500[PubMed]
  • 12. Voskaridou E, Terpos E, Michail S, Hantzi E, Anagnostopoulos A, Margeli A, et al. Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia. Kidney Int. 2006; 69(11): 2037-42[DOI][PubMed]
  • 13. Jafari HM, Vahidshahi K, Kosaryan M, Karami H, Reza Mahdavi M, Ehteshami S. Major beta-thalassemia, use of desferiexamine and renal proximal tubular damage. Bratisl Lek Listy. 2011; 112(5): 278-81[PubMed]
  • 14. Hamed EA, ElMelegy NT. Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Ital J Pediatr. 2010; 36: 39[DOI][PubMed]
  • 15. Jalali A, Khalilian H, Ahmadzadeh A, Sarvestani S, Rahim F, Zandian K, et al. Renal function in transfusion-dependent pediatric beta-thalassemia major patients. Hematology. 2011; 16(4): 249-54[DOI][PubMed]
  • 16. Uysal Z, Akar N, Kemahli S, Dincer N, Arcasoy A. Desferrioxamine and urinary zinc excretion in beta-thalassemia major. Pediatr Hematol Oncol. 1993; 10(3): 257-60[DOI][PubMed]
  • 17. Cianciulli P, Sollecito D, Sorrentino F, Forte L, Gilardi E, Massa A, et al. Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy. Kidney Int. 1994; 46(2): 467-70[DOI][PubMed]
  • 18. Boturao-Neto E, Marcopito LF, Zago MA. Urinary iron excretion induced by intravenous infusion of deferoxamine in beta-thalassemia homozygous patients. Braz J Med Biol Res. 2002; 35(11): 1319-28[DOI][PubMed]
  • 19. Wang CH, Wu KH, Tsai FJ, Peng CT, Tsai CH. Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients. Hemoglobin. 2006; 30(2): 257-62[DOI][PubMed]
  • 20. Kattamis A, Kassou C, Berdousi H, Ladis V, Papassotiriou I, Kattamis C. Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion. Haematologica. 2003; 88(12): 1423-5[PubMed]
  • 21. Oktenli C, Bulucu F. Renal tubular dysfunction in a patient with beta-thalassemia minor. Nephron. 2002; 92(1): 222-3[DOI]
  • 22. Cetin T, Oktenli C, Ozgurtas T, Yenicesu M, Sanisoglu SY, Oguz Y, et al. Renal tubular dysfunction in beta-thalassemia minor. Am J Kidney Dis. 2003; 42(6): 1164-8[DOI][PubMed]
  • 23. Kalman S, Atay AA, Sakallioglu O, Ozgurtas T, Gok F, Kurt I, et al. Renal tubular function in children with beta-thalassemia minor. Nephrology (Carlton). 2005; 10(5): 427-9[DOI][PubMed]
  • 24. Sumboonnanonda A, Malasit P, Tanphaichitr VS, Ong-ajyooth S, Petrarat S, Vongjirad A. Renal tubular dysfunction in alpha-thalassemia. Pediatr Nephrol. 2003; 18(3): 257-60[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments